Although the reduction of sK+ at 4 hours was similar in the sodium zirconium cyclosilicate and placebo groups, there were signals indicative of incremental benefit of sodium zirconium cyclosilicate when used in addition to insulin and glucose for the emergency treatment of hyperkalemia. The gene discussed is INS; the disease is Hyperkalemia.